Gwo Xi Stem Cell Applied Technology Co. , Ltd

NT$20.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6704Healthcare
Country Taiwan
PE (Fwd) •••
TSR 4Y CAGR (20.10%)
Div yield —
ROE (14.43%)
Biotechnology
Beta (5Y) 0.14
PE TTM —
TSR TTM (27.67%)
Mkt cap NT$1.919B
ROIC (5.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$22
7.64%
(75.10%)
Hold 12|5|12|10|4
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.45
0.44
0.46
0.45
30.80%
16.88%
18.26%
4.30%
RevenueNT$M
89.03
90.31
93.50
91.15
1.63%
2.58%
2.17%
1.31%
Peers (US$56.22M)
Cap (US$)
PE
59.75M
139.8x
56.15M
—
Capital
TTM
5Y
10Y
Leveragex
0.401
—
—
EBIT/Intx
1.340
0.149
0.163
Own earn%
(142.93)
(11.21)
(9.89)
Sh yield%
14.60
30.37
26.80
Owners
Insiders/Inst%
3.47
53.91
Short interest%
5.39
SBC / revenue%
2.23
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
4–12
$1 testx
—
Incr. ROIC%
3